Brief: Newron Pharmaceuticals H1 Net Loss Of EUR 10.5 Million

Newron Pharmaceuticals SpA

15/09/2020 06:08

Sept 15 (Reuters) - Newron Pharmaceuticals SpA  NWRN.S :
    * FOR THE FIRST SIX MONTHS OF 2020, NEWRON REPORTED A NET
LOSS OF
EUR 10.5 MILLION, COMPARED TO EUR 14.0 MILLION IN THE SAME
PERIOD IN 2019
    * NEWRON’S H1 RESEARCH AND DEVELOPMENT EXPENSES DECLINED TO
EUR
7.8 MILLION FROM EUR 10.3 MILLION IN 2019

Source text: https://bit.ly/3mn5owI
Further company coverage:  NWRN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))